Over the 90-day window ending January 10, 2026, Biomarin Pharmaceutical's three dominant insider ownership positions are held by Director Jean Jacques Bienaime (473.89K shares), President And Worldwide R&D Henry J Fuchs (185.07K shares), Chief Executive Officer Alexander Hardy (159.39K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Jean Jacques Bienaime | 473,892 | 21 May, 2024 | |
| Henry J Fuchs | President And Worldwide R&D | 185,074 | 17 Sep, 2024 |
| Alexander Hardy | Chief Executive Officer | 159,388 | 02 Dec, 2025 |
| Richard A Meier | 127,426 | 22 May, 2025 | |
| Brian Mueller | Evp And Chief Financial Officer | 99,781 | 18 Mar, 2025 |
| Elaine J Heron | 97,720 | 04 Jun, 2024 | |
| George Eric Davis | Evp And Chief Legal Officer | 82,915 | 18 Mar, 2025 |
| Charles Greg Guyer | Evp And Chief Technical Officer | 80,838 | 18 Mar, 2025 |
| Jeffrey Robert Ajer | Evp And Chief Commercial Officer | 66,767 | 06 May, 2024 |
| David E I Pyott | 49,750 | 23 May, 2024 | |
| Gregory R Friberg | Evp And Chief R&D Officer | 43,506 | 02 Oct, 2025 |
| Robert J. Hombach | 41,870 | 22 May, 2025 | |
| Willard H Dere | 38,950 | 22 May, 2025 | |
| Elizabeth M Anderson | 34,450 | 22 May, 2025 | |
| V Bryan Lawlis | 33,140 | 24 May, 2023 | |
| Dennis Slamon | 31,299 | 20 Mar, 2024 | |
| Cristin Hubbard | Evp And Chief Commercial Officer | 30,545 | 22 May, 2025 |
| Maykin Ho | 28,010 | 22 May, 2025 | |
| Mark J Alles | 15,095 | 24 May, 2023 | |
| Erin Burkhart | Gvp And Chief Accounting Officer | 14,173 | 20 May, 2025 |
| Barbara W. Bodem | 13,555 | 22 May, 2025 | |
| Mark J Enyedy | 13,550 | 22 May, 2025 | |
| Athena Countouriotis | 13,550 | 22 May, 2025 | |
| Timothy P Walbert | 9,780 | 22 May, 2025 | |
| Ian T Clark | 7,000 | 05 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Dec, 2025 | Alexander Hardy | Common Stock | D | 16,570 | $55.03 | 159,388 | D | F |
| 30 Sep, 2025 | Gregory R Friberg | Common Stock | D | 3,304 | $54.16 | 43,506 | D | F |
| 30 Sep, 2025 | Gregory R Friberg | - | - | 43,506 | D | |||
| 01 Aug, 2025 | Ian T Clark | - | - | 7,000 | D | |||
| 01 Aug, 2025 | Ian T Clark | Common Stock | A | 7,000 | $0.00 | 7,000 | D | A |
| 20 May, 2025 | Richard A Meier | Common Stock | A | 6,650 | $0.00 | 127,426 | D | A |
| 20 May, 2025 | Willard H Dere | Common Stock | A | 6,650 | $0.00 | 38,950 | D | A |
| 20 May, 2025 | Timothy P Walbert | Common Stock | A | 6,650 | $0.00 | 9,780 | D | A |
| 20 May, 2025 | Robert J. Hombach | Common Stock | A | 6,650 | $0.00 | 41,870 | D | A |
| 20 May, 2025 | Athena Countouriotis | Common Stock | A | 6,650 | $0.00 | 13,550 | D | A |
| 20 May, 2025 | Mark J Enyedy | Common Stock | A | 6,650 | $0.00 | 13,550 | D | A |
| 20 May, 2025 | Maykin Ho | Common Stock | A | 6,650 | $0.00 | 28,010 | D | A |
| 20 May, 2025 | Barbara W. Bodem | Common Stock | A | 6,650 | $0.00 | 13,555 | D | A |
| 20 May, 2025 | Elizabeth M Anderson | Common Stock | A | 6,650 | $0.00 | 34,450 | D | A |
| 20 May, 2025 | Elizabeth M Anderson | - | - | 34,450 | D | |||
| 20 May, 2025 | Erin Burkhart | - | - | 14,173 | D | |||
| 20 May, 2025 | Erin Burkhart | Common Stock | D | 1,786 | $59.31 | 14,173 | D | S |
| 20 May, 2025 | Cristin Hubbard | Common Stock | D | 2,155 | $59.93 | 30,545 | D | F |
| 19 May, 2025 | Erin Burkhart | - | - | 15,959 | D | |||
| 19 May, 2025 | Erin Burkhart | Common Stock | D | 996 | $59.27 | 15,959 | D | F |